VM:CA:CDX-Voyageur Minerals Ltd. (CAD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic | TSX Venture Exchange

Last Closing

USD 0.17

Change

+0.01 (+3.03)%

Market Cap

USD 0.28M

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Voyageur Minerals Ltd develops near term cash flow on barite projects in British Columbia, Canada and explores and develops lithium brine projects in Utah USA.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
RX:CA Biosyent Inc.

+0.06 (+0.54%)

USD 0.13B
SBBC:CA Simply Better Brands Corp

-0.02 (-1.75%)

USD 0.10B
LOVE:CA Cannara Biotech Inc

+0.05 (+4.17%)

USD 0.10B
HASH:CA Simply Solventless Concentrate..

-0.01 (-1.45%)

USD 0.08B
ZYUS:CA ZYUS Life Sciences Corporation

N/A

USD 0.06B
LSL:CA LSL Pharma Group Inc.

+0.02 (+5.80%)

USD 0.04B
DB:CA Decibel Cannabis Company Inc

N/A

USD 0.04B
ROMJ:CA Rubicon Organics Inc

+0.01 (+1.32%)

USD 0.02B
PCLO:CA Pharmacielo Ltd

-0.01 (-6.25%)

USD 0.01B
ELXR:CA Elixxer Ltd

N/A

USD 0.01B

ETFs Containing VM:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange (TSX Venture Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 100.00% 100% F 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.00% 100% F 96% N/A
Trailing 12 Months  
Capital Gain 142.86% 82% B 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 142.86% 82% B 90% A-
Trailing 5 Years  
Capital Gain 100.00% 89% A- 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.00% 89% A- 83% B
Average Annual (5 Year Horizon)  
Capital Gain 15.14% 68% D+ 68% D+
Dividend Return 15.14% 68% D+ 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 61.20% 47% F 44% F
Risk Adjusted Return 24.73% 74% C 75% C
Market Capitalization 0.28M 63% D 74% C

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector